<DOC>
	<DOCNO>NCT01575587</DOCNO>
	<brief_summary>The purpose study evaluate effect timing food intake systemic abiraterone exposure observe healthy adult Japanese Caucasian men .</brief_summary>
	<brief_title>A Study Assess Effect Timing Food Intake Pharmacokinetics Abiraterone Following Single-Dose Administration Abiraterone Acetate Tablets Healthy Caucasian Japanese Men</brief_title>
	<detailed_description>This randomize ( individual assign chance study treatment ) , open-label ( individual know identity study treatment ) , single dose , 4-way crossover study abiraterone acetate approximately 48 healthy adult Japanese Caucasian men . For crossover design , treatment sequence define follow : 1 - ADBC , 2 - BACD , 3 - CBDA , 4 - DCAB ; Treatment A = abiraterone acetate administer fasted state , Treatment B = standardize meal administer 1 hour abiraterone acetate dose , Treatment C = standardize meal administer 2 hour abiraterone acetate dose , Treatment D = standardize meal administer 2 hour 2 hour abiraterone acetate dose . This study consist screen period follow four open-label treatment period separate washout period least 14 day dose . Eligible participant randomly assign Day 1 1 4 treatment sequence differ regard timing food intake and/or dose single dose 1000 mg abiraterone acetate . Serial pharmacokinetic ( study body drug ) sample collect open-label treatment phase detail protocol . Safety monitor throughout study . End-of-study assessment perform Day 4 Period 4 upon early withdrawal .</detailed_description>
	<mesh_term>Abiraterone Acetate</mesh_term>
	<criteria>Healthy Caucasian Japanese male individual . Body mass index 18 30 kg/m2 . Body weight &gt; =50 kg . A normal 12lead electrocardiogram . History current clinically significant medical illness investigator considers exclude participant could interfere interpretation study result . Presence sexual dysfunction ( abnormal libido , erectile dysfunction , etc . ) medical condition would affect sexual function . History alcohol consumption 4 drink daily within 1 year prior screen unwillingness abstain alcoholcontaining food beverage within 24 hour Day1 study completion . History , reason believe participant history drug alcohol abuse within past 5 year . Positive test human immunodeficiency virus 1 2 antibody , hepatitis B surface antigen , hepatitis C antibody . History smoking use nicotinecontaining substance within previous 2 month , determine medical history participant 's verbal report .</criteria>
	<gender>Male</gender>
	<minimum_age>25 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>January 2014</verification_date>
	<keyword>Pharmacology</keyword>
	<keyword>Pharmacokinetics</keyword>
	<keyword>Pharmacodynamics</keyword>
	<keyword>Abiraterone acetate</keyword>
	<keyword>Food intake</keyword>
	<keyword>Caucasion</keyword>
	<keyword>Japanese</keyword>
	<keyword>Healthy</keyword>
</DOC>